{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:17:55Z","timestamp":1793866675506,"version":"4.6.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T00:00:00Z","timestamp":1686268800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["F32AG062045"],"award-info":[{"award-number":["F32AG062045"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG058639"],"award-info":[{"award-number":["R01AG058639"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["1K23GM150110"],"award-info":[{"award-number":["1K23GM150110"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM135094"],"award-info":[{"award-number":["T32GM135094"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM135094"],"award-info":[{"award-number":["T32GM135094"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R01GM120484"],"award-info":[{"award-number":["R01GM120484"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32GM135094"],"award-info":[{"award-number":["T32GM135094"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006538","name":"School of Medicine, Vanderbilt University","doi-asserted-by":"publisher","award":["Vanderbilt Medical Scholars Program"],"award-info":[{"award-number":["Vanderbilt Medical Scholars Program"]}],"id":[{"id":"10.13039\/100006538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006538","name":"School of Medicine, Vanderbilt University","doi-asserted-by":"publisher","award":["Vanderbilt Faculty Research Scholar Program"],"award-info":[{"award-number":["Vanderbilt Faculty Research Scholar Program"]}],"id":[{"id":"10.13039\/100006538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R25 NS088248"],"award-info":[{"award-number":["R25 NS088248"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R25 NS088248"],"award-info":[{"award-number":["R25 NS088248"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["R25 NS088248"],"award-info":[{"award-number":["R25 NS088248"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL111111"],"award-info":[{"award-number":["R01HL111111"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL111111"],"award-info":[{"award-number":["R01HL111111"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01RX002992"],"award-info":[{"award-number":["I01RX002992"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010659","name":"Eastern Association for the Surgery of Trauma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007206","name":"Vanderbilt Institute for Clinical and Translational Research","doi-asserted-by":"publisher","award":["UL1TR002243"],"award-info":[{"award-number":["UL1TR002243"]}],"id":[{"id":"10.13039\/100007206","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Crit Care"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To evaluate the safety, feasibility, and efficacy of combined adrenergic blockade with propranolol and clonidine in patients with severe traumatic brain injury (TBI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Administration of adrenergic blockade after severe TBI is common. To date, no prospective trial has rigorously evaluated this common therapy for benefit.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This phase II, single-center, double-blinded, pilot randomized placebo-controlled trial included patients aged 16\u201364\u00a0years with severe TBI (intracranial hemorrhage and Glasgow Coma Scale score\u2009\u2264\u20098) within 24\u00a0h of ICU admission. Patients received propranolol and clonidine or double placebo for 7\u00a0days. The primary outcome was ventilator-free days (VFDs) at 28\u00a0days. Secondary outcomes included catecholamine levels, hospital length of stay, mortality, and long-term functional status. A planned futility assessment was performed mid-study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Dose compliance was 99%, blinding was intact, and no open-label agents were used. No treatment patient experienced dysrhythmia, myocardial infarction, or cardiac arrest. The study was stopped for futility after enrolling 47 patients (26 placebo, 21 treatment), per a priori stopping rules. There was no significant difference in VFDs between treatment and control groups [0.3\u00a0days, 95% CI (\u2212\u20095.4, 5.8), <jats:italic>p<\/jats:italic>\u2009=\u20091.0]. Other than improvement of features related to sympathetic hyperactivity (mean difference in Clinical Features Scale (CFS) 1.7 points, CI (0.4, 2.9), <jats:italic>p<\/jats:italic>\u2009=\u20090.012), there were no between-group differences in the secondary outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Despite the safety and feasibility of adrenergic blockade with propranolol and clonidine after severe TBI, the intervention did not alter the VFD outcome. Given the widespread use of these agents in TBI care, a multi-center investigation is warranted to determine whether adrenergic blockade is of therapeutic benefit in patients with severe TBI.<\/jats:p>\n                <jats:p><jats:italic>Trial Registration Number<\/jats:italic> NCT01322048.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13054-023-04479-6","type":"journal-article","created":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T11:02:30Z","timestamp":1686308550000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Effect of propranolol and clonidine after severe traumatic brain injury: a pilot randomized clinical trial"],"prefix":"10.1186","volume":"27","author":[{"given":"Mina F.","family":"Nordness","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia W.","family":"Maiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura D.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Koyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika L.","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shayan","family":"Rakhit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"de Riesthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cari L.","family":"Motuzas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madison R.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawniqua","family":"Williams Roberson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William J.","family":"Meurer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J.","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey T.","family":"Manley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik P.","family":"Pandharipande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur B.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,9]]},"reference":[{"key":"4479_CR1","unstructured":"(CDC) CfDCaP: CDC grand rounds: reducing severe traumatic brain injury in the United States. MMWR Morb Mortal Wkly Rep. 2013:62(27):549\u2013552."},{"issue":"5","key":"4479_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/00001199-200609000-00001","volume":"21","author":"JA Langlois","year":"2006","unstructured":"Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil. 2006;21(5):375\u20138.","journal-title":"J Head Trauma Rehabil"},{"key":"4479_CR3","unstructured":"National Academies of Sciences E, and Medicine 2022: Traumatic Brain\u00a0Injury: A Roadmap for Accelerating Progress. In. Washington, DC; 2022."},{"key":"4479_CR4","unstructured":"Traumatic Brain Injury Related Emergency Department Visits, Hospitalizations and Deaths [https:\/\/www.cdc.gov\/traumaticbraininjury\/data\/tbi-edhd.html]."},{"issue":"2","key":"4479_CR5","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1089\/neu.2006.0024","volume":"24","author":"AI Maas","year":"2007","unstructured":"Maas AI, Marmarou A, Murray GD, Teasdale SG, Steyerberg EW. Prognosis and clinical trial design in traumatic brain injury: the IMPACT study. J Neurotrauma. 2007;24(2):232\u20138.","journal-title":"J Neurotrauma"},{"issue":"5","key":"4479_CR6","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/MCC.0b013e3283307a26","volume":"15","author":"DK Menon","year":"2009","unstructured":"Menon DK, Zahed C. Prediction of outcome in severe traumatic brain injury. Curr Opin Crit Care. 2009;15(5):437\u201341.","journal-title":"Curr Opin Crit Care"},{"issue":"6","key":"4479_CR7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3171\/jns.1987.66.6.0875","volume":"66","author":"PD Woolf","year":"1987","unstructured":"Woolf PD, Hamill RW, Lee LA, Cox C, McDonald JV. The predictive value of catecholamines in assessing outcome in traumatic brain injury. J Neurosurg. 1987;66(6):875\u201382.","journal-title":"J Neurosurg"},{"issue":"1","key":"4479_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1097\/TA.0b013e31802d972b","volume":"62","author":"S Arbabi","year":"2007","unstructured":"Arbabi S, Campion EM, Hemmila MR, Barker M, Dimo M, Ahrns KS, Niederbichler AD, Ipaktchi K, Wahl WL. Beta-blocker use is associated with improved outcomes in adult trauma patients. J Trauma. 2007;62(1):56\u201361 (discussion 61\u201352).","journal-title":"J Trauma"},{"issue":"3","key":"4479_CR9","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.jamcollsurg.2007.10.005","volume":"206","author":"K Inaba","year":"2008","unstructured":"Inaba K, Teixeira PG, David JS, Chan LS, Salim A, Brown C, Browder T, Beale E, Rhee P, Demetriades D. Beta-blockers in isolated blunt head injury. J Am Coll Surg. 2008;206(3):432\u20138.","journal-title":"J Am Coll Surg"},{"key":"4479_CR10","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.jcrc.2017.05.035","volume":"41","author":"Z Chen","year":"2017","unstructured":"Chen Z, Tang L, Xu X, Wei X, Wen L, Xie Q. Therapeutic effect of beta-blocker in patients with traumatic brain injury: a systematic review and meta-analysis. J Crit Care. 2017;41:240\u20136.","journal-title":"J Crit Care"},{"issue":"6","key":"4479_CR11","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00068-017-0779-5","volume":"43","author":"R Ahl","year":"2017","unstructured":"Ahl R, Thelin EP, Sjolin G, Bellander BM, Riddez L, Talving P, Mohseni S. beta-Blocker after severe traumatic brain injury is associated with better long-term functional outcome: a matched case control study. Eur J Trauma Emerg Surg. 2017;43(6):783\u20139.","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"4","key":"4479_CR12","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.3171\/FOC.2008.25.10.E8","volume":"25","author":"TY Tran","year":"2008","unstructured":"Tran TY, Dunne IE, German JW. Beta blockers exposure and traumatic brain injury: a literature review. Neurosurg Focus. 2008;25(4):E8.","journal-title":"Neurosurg Focus"},{"issue":"1","key":"4479_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/TA.0b013e31802d02d0","volume":"62","author":"BA Cotton","year":"2007","unstructured":"Cotton BA, Snodgrass KB, Fleming SB, Carpenter RO, Kemp CD, Arbogast PG, Morris JA Jr. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma. 2007;62(1):26\u201333 (discussion 33\u201325).","journal-title":"J Trauma"},{"issue":"3","key":"4479_CR14","first-page":"503","volume":"63","author":"WP Riordan Jr","year":"2007","unstructured":"Riordan WP Jr, Cotton BA, Norris PR, Waitman LR, Jenkins JM, Morris JA Jr. Beta-blocker exposure in patients with severe traumatic brain injury (TBI) and cardiac uncoupling. J Trauma. 2007;63(3):503\u201310 (discussion 510\u2013501).","journal-title":"J Trauma"},{"issue":"17","key":"4479_CR15","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1517\/14656566.2010.511613","volume":"11","author":"AK Chan","year":"2010","unstructured":"Chan AK, Cheung CW, Chong YK. Alpha-2 agonists in acute pain management. Expert Opin Pharmacother. 2010;11(17):2849\u201368.","journal-title":"Expert Opin Pharmacother"},{"issue":"22","key":"4479_CR16","doi-asserted-by":"publisher","first-page":"2644","DOI":"10.1001\/jama.298.22.2644","volume":"298","author":"PP Pandharipande","year":"2007","unstructured":"Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, Shintani AK, Thompson JL, Jackson JC, Deppen SA, et al. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007;298(22):2644\u201353.","journal-title":"JAMA"},{"issue":"5","key":"4479_CR17","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1001\/jama.2009.56","volume":"301","author":"RR Riker","year":"2009","unstructured":"Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, Whitten P, Margolis BD, Byrne DW, Ely EW, et al. Dexmedetomidine vs midazolam for sedation of critically ill patients: a randomized trial. JAMA. 2009;301(5):489\u201399.","journal-title":"JAMA"},{"issue":"4","key":"4479_CR18","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1213\/00000539-199110000-00016","volume":"73","author":"WE Hoffman","year":"1991","unstructured":"Hoffman WE, Cheng MA, Thomas C, Baughman VL, Albrecht RF. Clonidine decreases plasma catecholamines and improves outcome from incomplete ischemia in the rat. Anesth Analg. 1991;73(4):460\u20134.","journal-title":"Anesth Analg"},{"issue":"3","key":"4479_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1399-6576.1995.tb04075.x","volume":"39","author":"B Asgeirsson","year":"1995","unstructured":"Asgeirsson B, Grande PO, Nordstrom CH, Berntman L, Messeter K, Ryding E. Effects of hypotensive treatment with alpha 2-agonist and beta 1-antagonist on cerebral haemodynamics in severely head injured patients. Acta Anaesthesiol Scand. 1995;39(3):347\u201351.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"4","key":"4479_CR20","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/00003246-199004000-00008","volume":"18","author":"D Payen","year":"1990","unstructured":"Payen D, Quintin L, Plaisance P, Chiron B, Lhoste F. Head injury: clonidine decreases plasma catecholamines. Crit Care Med. 1990;18(4):392\u20135.","journal-title":"Crit Care Med"},{"issue":"6","key":"4479_CR21","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1097\/SLA.0000000000002286","volume":"266","author":"AS Alali","year":"2017","unstructured":"Alali AS, Mukherjee K, McCredie VA, Golan E, Shah PS, Bardes JM, Hamblin SE, Haut ER, Jackson JC, Khwaja K, et al. Beta-blockers and traumatic brain injury: a systematic review, meta-analysis, and eastern association for the surgery of trauma guideline. Ann Surg. 2017;266(6):952\u201361.","journal-title":"Ann Surg"},{"issue":"6","key":"4479_CR22","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00068-017-0779-5","volume":"43","author":"R Ahl","year":"2017","unstructured":"Ahl R, Thelin EP, Sj\u00f6lin G, Bellander BM, Riddez L, Talving P, Mohseni S. \u03b2-Blocker after severe traumatic brain injury is associated with better long-term functional outcome: a matched case control study. Eur J Trauma Emerg Surg. 2017;43(6):783\u20139.","journal-title":"Eur J Trauma Emerg Surg"},{"issue":"2","key":"4479_CR23","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/TA.0000000000001747","volume":"84","author":"EJ Ley","year":"2018","unstructured":"Ley EJ, Leonard SD, Barmparas G, Dhillon NK, Inaba K, Salim A, O\u2019Bosky KR, Tatum D, Azmi H, Ball CG, et al. Beta blockers in critically ill patients with traumatic brain injury: Results from a multicenter, prospective, observational American Association for the Surgery of Trauma study. J Trauma Acute Care Surg. 2018;84(2):234\u201344.","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"4479_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/tsaco-2019-000307","volume":"4","author":"TJ Schroeppel","year":"2019","unstructured":"Schroeppel TJ, Sharpe JP, Shahan CP, Clement LP, Magnotti LJ, Lee M, Muhlbauer M, Weinberg JA, Tolley EA, Croce MA, et al. Beta-adrenergic blockade for attenuation of catecholamine surge after traumatic brain injury: a randomized pilot trial. Trauma Surg Acute Care Open. 2019;4(1): e000307.","journal-title":"Trauma Surg Acute Care Open"},{"key":"4479_CR25","doi-asserted-by":"crossref","unstructured":"Schulz KF, Altman DG, Moher D, Group C. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med. 2010;8:18.","DOI":"10.1186\/1741-7015-8-18"},{"key":"4479_CR26","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1186\/1745-6215-13-177","volume":"13","author":"MB Patel","year":"2012","unstructured":"Patel MB, McKenna JW, Alvarez JM, Sugiura A, Jenkins JM, Guillamondegui OD, Pandharipande PP. Decreasing adrenergic or sympathetic hyperactivity after severe traumatic brain injury using propranolol and clonidine (DASH After TBI Study): study protocol for a randomized controlled trial. Trials. 2012;13:177.","journal-title":"Trials"},{"issue":"9607","key":"4479_CR27","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0140-6736(08)60105-1","volume":"371","author":"TD Girard","year":"2008","unstructured":"Girard TD, Kress JP, Fuchs BD, Thomason JW, Schweickert WD, Pun BT, Taichman DB, Dunn JG, Pohlman AS, Kinniry PA, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008;371(9607):126\u201334.","journal-title":"Lancet"},{"issue":"8","key":"4479_CR28","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1097\/00003246-200208000-00016","volume":"30","author":"DA Schoenfeld","year":"2002","unstructured":"Schoenfeld DA, Bernard GR, Network A. Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome. Crit Care Med. 2002;30(8):1772\u20137.","journal-title":"Crit Care Med"},{"key":"4479_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1186\/1745-6215-15-499","volume":"15","author":"P Toft","year":"2014","unstructured":"Toft P, Olsen HT, Jorgensen HK, Strom T, Nibro HL, Oxlund J, Wian KA, Ytrebo LM, Kroken BA, Chew M. Non-sedation versus sedation with a daily wake-up trial in critically ill patients receiving mechanical ventilation (NONSEDA Trial): study protocol for a randomised controlled trial. Trials. 2014;15:499.","journal-title":"Trials"},{"issue":"10","key":"4479_CR30","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1164\/rccm.2107138","volume":"166","author":"CN Sessler","year":"2002","unstructured":"Sessler CN, Gosnell MS, Grap MJ, Brophy GM, O\u2019Neal PV, Keane KA, Tesoro EP, Elswick RK. The Richmond Agitation-Sedation Scale: validity and reliability in adult intensive care unit patients. Am J Respir Crit Care Med. 2002;166(10):1338\u201344.","journal-title":"Am J Respir Crit Care Med"},{"issue":"17","key":"4479_CR31","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1089\/neu.2013.3301","volume":"31","author":"IJ Baguley","year":"2014","unstructured":"Baguley IJ, Perkes IE, Fernandez-Ortega JF, Rabinstein AA, Dolce G, Hendricks HT, Consensus Working G. Paroxysmal sympathetic hyperactivity after acquired brain injury: consensus on conceptual definition, nomenclature, and diagnostic criteria. J Neurotrauma. 2014;31(17):1515\u201320.","journal-title":"J Neurotrauma"},{"issue":"10","key":"4479_CR32","doi-asserted-by":"publisher","first-page":"925","DOI":"10.3109\/02699052.2011.589797","volume":"25","author":"IE Perkes","year":"2011","unstructured":"Perkes IE, Menon DK, Nott MT, Baguley IJ. Paroxysmal sympathetic hyperactivity after acquired brain injury: a review of diagnostic criteria. Brain Inj. 2011;25(10):925\u201332.","journal-title":"Brain Inj"},{"issue":"2","key":"4479_CR33","first-page":"94","volume":"68","author":"WD Gouvier","year":"1987","unstructured":"Gouvier WD, Blanton PD, LaPorte KK, Nepomuceno C. Reliability and validity of the Disability Rating Scale and the Levels of Cognitive Functioning Scale in monitoring recovery from severe head injury. Arch Phys Med Rehabil. 1987;68(2):94\u20137.","journal-title":"Arch Phys Med Rehabil"},{"key":"4479_CR34","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2466\/pms.1958.8.3.271","volume":"8","author":"RM Reitan","year":"1958","unstructured":"Reitan RM. Validity of the trail making test as an indicator of organic brain damage. Percept Mot Skills. 1958;8:271\u20136.","journal-title":"Percept Mot Skills"},{"issue":"7","key":"4479_CR35","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/neu.2009.1076","volume":"27","author":"N von Steinbuchel","year":"2010","unstructured":"von Steinbuchel N, Wilson L, Gibbons H, Hawthorne G, Hofer S, Schmidt S, Bullinger M, Maas A, Neugebauer E, Powell J, et al. Quality of Life after Brain Injury (QOLIBRI): scale development and metric properties. J Neurotrauma. 2010;27(7):1167\u201385.","journal-title":"J Neurotrauma"},{"issue":"8","key":"4479_CR36","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1089\/neu.1998.15.573","volume":"15","author":"JT Wilson","year":"1998","unstructured":"Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: guidelines for their use. J Neurotrauma. 1998;15(8):573\u201385.","journal-title":"J Neurotrauma"},{"issue":"15","key":"4479_CR37","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1001\/jama.2021.10174","volume":"326","author":"WJ Meurer","year":"2021","unstructured":"Meurer WJ, Tolles J. Interim analyses during group sequential clinical trials. JAMA. 2021;326(15):1524\u20135.","journal-title":"JAMA"},{"issue":"2","key":"4479_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/0197-2456(90)90005-M","volume":"11","author":"WD Dupont","year":"1990","unstructured":"Dupont WD, Plummer WD Jr. Power and sample size calculations. A review and computer program. Control Clin Trials. 1990;11(2):116\u201328.","journal-title":"Control Clin Trials"},{"issue":"1","key":"4479_CR39","doi-asserted-by":"publisher","first-page":"103","DOI":"10.2307\/2529712","volume":"31","author":"SJ Pocock","year":"1975","unstructured":"Pocock SJ, Simon R. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics. 1975;31(1):103\u201315.","journal-title":"Biometrics"},{"issue":"Suppl 1","key":"4479_CR40","first-page":"S287","volume":"9","author":"LF Marshall","year":"1992","unstructured":"Marshall LF, Marshall SB, Klauber MR, Van Berkum CM, Eisenberg H, Jane JA, Luerssen TG, Marmarou A, Foulkes MA. The diagnosis of head injury requires a classification based on computed axial tomography. J Neurotrauma. 1992;9(Suppl 1):S287-292.","journal-title":"J Neurotrauma"},{"issue":"1","key":"4479_CR41","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s40141-018-0175-z","volume":"6","author":"MF Mirhoseini","year":"2018","unstructured":"Mirhoseini MF, Hosay MA, McPherson M, Patel MB. Paroxysmal sympathetic hyperactivity: diagnostic criteria, complications, and treatment after traumatic brain injury. Curr Phys Med Rehabil Rep. 2018;6(1):81\u20138.","journal-title":"Curr Phys Med Rehabil Rep"},{"issue":"11","key":"4479_CR42","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1089\/neu.2010.1391","volume":"27","author":"LQ Lv","year":"2010","unstructured":"Lv LQ, Hou LJ, Yu MK, Qi XQ, Chen HR, Chen JX, Hu GH, Luo C, Lu YC. Prognostic influence and magnetic resonance imaging findings in paroxysmal sympathetic hyperactivity after severe traumatic brain injury. J Neurotrauma. 2010;27(11):1945\u201350.","journal-title":"J Neurotrauma"},{"issue":"3","key":"4479_CR43","first-page":"538","volume":"71","author":"LQ Lv","year":"2011","unstructured":"Lv LQ, Hou LJ, Yu MK, Qi XQ, Chen HR, Chen JX, Hu GH, Luo C, Lu YC. Risk factors related to dysautonomia after severe traumatic brain injury. J Trauma. 2011;71(3):538\u201342.","journal-title":"J Trauma"},{"issue":"9","key":"4479_CR44","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S1474-4422(17)30259-4","volume":"16","author":"G Meyfroidt","year":"2017","unstructured":"Meyfroidt G, Baguley IJ, Menon DK. Paroxysmal sympathetic hyperactivity: the storm after acute brain injury. Lancet Neurol. 2017;16(9):721\u20139.","journal-title":"Lancet Neurol"},{"issue":"2","key":"4479_CR45","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/JNN.0000000000000207","volume":"48","author":"S Samuel","year":"2016","unstructured":"Samuel S, Allison TA, Lee K, Choi HA. Pharmacologic management of paroxysmal sympathetic hyperactivity after brain injury. J Neurosci Nurs J Am Assoc Neurosci Nurses. 2016;48(2):82\u20139.","journal-title":"J Neurosci Nurs J Am Assoc Neurosci Nurses"},{"issue":"5","key":"4479_CR46","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1097\/TA.0000000000002484","volume":"87","author":"M Zeeshan","year":"2019","unstructured":"Zeeshan M, Hamidi M, O\u2019Keeffe T, Bae EH, Hanna K, Friese RS, Kulvatunyou N, Zakaria ER, Gries L, Tang A, et al. Propranolol attenuates cognitive, learning, and memory deficits in a murine model of traumatic brain injury. J Trauma Acute Care Surg. 2019;87(5):1140\u20137.","journal-title":"J Trauma Acute Care Surg"},{"issue":"2","key":"4479_CR47","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1097\/TA.0000000000001747","volume":"84","author":"EJ Ley","year":"2018","unstructured":"Ley EJ, Leonard SD, Barmparas G, Dhillon NK, Inaba K, Salim A, O\u2019Bosky KR, Tatum D, Azmi H, Ball CG, et al. Beta blockers in critically ill patients with traumatic brain injury: results from a multicenter, prospective, observational American Association for the Surgery of Trauma study. J Trauma Acute Care Surg. 2018;84(2):234\u201344.","journal-title":"J Trauma Acute Care Surg"},{"issue":"1","key":"4479_CR48","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/TA.0000000000001852","volume":"85","author":"SS Humble","year":"2018","unstructured":"Humble SS, Wilson LD, Wang L, Long DA, Smith MA, Siktberg JC, Mirhoseini MF, Bhatia A, Pruthi S, Day MA, et al. Prognosis of diffuse axonal injury with traumatic brain injury. J Trauma Acute Care Surg. 2018;85(1):155\u20139.","journal-title":"J Trauma Acute Care Surg"}],"container-title":["Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04479-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13054-023-04479-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13054-023-04479-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T12:06:29Z","timestamp":1686312389000},"score":1,"resource":{"primary":{"URL":"https:\/\/ccforum.biomedcentral.com\/articles\/10.1186\/s13054-023-04479-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,9]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4479"],"URL":"https:\/\/doi.org\/10.1186\/s13054-023-04479-6","relation":{},"ISSN":["1364-8535"],"issn-type":[{"value":"1364-8535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,9]]},"assertion":[{"value":"6 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were approved by the Institutional Review Board (IRB) at Vanderbilt University Medical Center. The research was carried out in accordance with IRB standards. Written informed consent was obtained from eligible patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Pfizer, Inc. (previously Hospira Inc.) has provided unrelated research support to PPP. Haemonetics, Inc. has provided unrelated research support to MBP. For the remaining authors, no competing interests were declared.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"228"}}